Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 DSM Invests in Fruitflow Developer - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

DSM Invests in Fruitflow Developer

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World


Netherlands-based DSM Venturing, the corporate venturing unit of Royal DSM N.V., has acquired an equity stake of 29.3% in Provexis plc, becoming the company’s largest shareholder. Provexis develops and licenses ingredients for the functional food, medical food and dietary supplement markets. Its leading product is Fruitflow, a bioactive, patented extract from tomatoes that improves blood flow, which is important to maintaining a healthy heart and cardiovascular system. Krijn Rietveld, Senior Vice President New Business Development at DSM Nutritional Products, has been appointed non-executive director of the company. The investment seems consistent with DSM’s strategy of focusing on cardiovascular and digestive health ingredients for the functional food and dietary supplement markets.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics